focus -WSS

focus

author：fashion 2025-09-02 09:56:23 - browse：3378

Judge's gavel — Legal experts unpacked the pharmaceutical industry's scattershot approach to challenging Medicare's new power to negotiate drug prices. Adobe

WASHINGTON — The pharmaceutical industry has been filing a lawsuit here, there, and pretty much everywhere.

Drugmakers lost a two-decade long lobbying fight in Congress last summer when Democrats gave Medicare more power to choose what it pays for prescription drugs. Now, they’re taking their battle to the courts.

Merck filed suit in the District of Columbia. Bristol Myers Squibb filed in New Jersey. The Chamber of Commerce filed in Ohio. PhRMA filed in Texas. And there’s no reason to believe the barrage of lawsuits will stop anytime soon.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Biden outlines 'new path' to provide student loan relief after Supreme Court rejection
Next article： iTeos Therapeutics debuts first data on TIGIT

WSS

Annovis Bio delivers candor, but not confidence, on Parkinson’s study

Alabama IVF ruling threatens families facing fatal genetic disease

Prosthetic arm enables patients to feel the objects they grip

Alabama frozen embryo ruling has major implications for IVF clinics

Neurocrine Biosciences, biotech based in San Diego, joins PhRMA

The Readout: Abbvie and Humira, CRISPR in utero, Annovis Bio

focus

focus

knowledge

Hepatitis C has a cure — but many Americans still lack access to it

Childbirth

How one medical school became remarkably diverse

Readout Newsletter: Wegovy, dialysis, Humira, Vir, and more

Trump demands the U.S. pay no more for drugs than other countries … again

Addiction doctors spar with methadone clinics over legislation

Malaria cases in Florida and Texas: Here’s what you need to know

Readout Newsletter: Moderna bird flu vaccine, Biohaven, ASCO

Peter Hotez and the public health issue of online harassment

Addiction doctors spar with methadone clinics over legislation

explore

A solution to the after

Dark money group runs ads on China biotech bill

Adam's Biotech Scorecard: Do Sarepta's exon

Community Health Systems hospitals under DOJ investigation

Cyberattack on UnitedHealth subsidiary cripples pharmacies, hospitals

NIH study of ME/CFS points to clear biological hallmarks

explore

focus

entertainment

hotspot